Researchers from places like the University of Edinburgh have been studying zilebesiran, and the early results are exciting.

Because of this, scientists have been looking for easier ways to help people control their blood pressure. One new solution ...

A single subcutaneous injection of the investigational drug zilebesiran, when added to existing treatment with a standard antihypertensive medication, reduced systolic blood pressure by between 4 to ...

A major breakthrough has been made for millions of people suffering with high blood pressure, which is the leading cause of heart attacks and strokes. British medics have been trialling the world’s ...

Results from a clinical trial led by researchers from Queen Mary University of London, published today in JAMA, show that giving people with high blood pressure an injection every six months can lead ...

A single injection of the investigational antihypertensive agent zilebesiran (Alnylam Pharmaceuticals) effectively lowered blood pressure in adults with mild to moderate hypertension for up to 6 ...

Alnylam Pharmaceuticals will receive $310 million in cash from the Swiss drug giant Roche Holding AG and be eligible for as much as $2.5 billion more in a deal to jointly develop and market the ...

SUBJECT:Pressurized Rescue Tool SystemsTOPIC:High-Pressure Injection InjuriesOBJECTIVE:Understand the safety concerns associated specifically with operating equipment utilizing pressurized ...

Weight-loss injections such as Mounjaro containing tirzepatide and Wegovy containing semaglutide have demonstrated strong ...